SecBot SecBot
Insider Cluster (3 insiders) ·Filed May 22, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 3 insiders, $0.3M total
Actionable Insight • Neutral

These sales are routine tax-motivated transactions and carry no informational signal. UTHR has strong analyst sentiment and no material insider selling signal. Monitor the next earnings release and any change in the ongoing share buyback or pipeline developments for directional cues.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$575.25
T+0 close · May 22, 2026 · via day close
Latest settled
−8.35%
T+60 · $527.21
Vs SPY
−10.81%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 26 $575.25entry
  2. T+1 · 6mo ago −1.31%α −1.32% · $567.74
  3. T+5 · 6mo ago −6.14%α −7.36% · $539.91
  4. T+20 · 5mo ago −5.38%α −3.11% · $544.33
  5. T+60 · 3mo ago −8.35%α −10.81% · $527.21

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three UTHR insiders including the CEO, CFO, and EVP & General Counsel executed a series of option exercises and small open-market sales (total ~$331K) over May 18-21, 2026. The aggregate dollar value is negligible relative to the $24.0B market cap (~0.0014%), and the trades follow a pattern of near-simultaneous multi-leg option exercises with de minimis share sales, consistent with routine tax-withholding or cashless-exercise settlements, not informed selling.

Key Financial Metrics

Direction
selling
Total Value
$331.0K
Insiders
3

Key Facts

  • Three insiders, CEO Martine A. Rothblatt, CFO James Edgemond, and EVP Paul A. Mahon, sold a combined ~$331K of shares on the open market.
  • Sales are tiny relative to market cap (0.0014% of $24.0B), below the 0.1% threshold for materiality.
  • Every sale is paired with a simultaneous derivative exercise (option exercise at $0 to $146.03), indicating a tax-withholding or cashless exercise pattern.
  • All sales occurred within a 4-day window (May 18-21), consistent with a blackout-window opening post-earnings.
  • The common stock has been strong, with analyst consensus 77% bullish and a prior cluster of sells totaling the same $331K noted in the 30d snapshot, this appears to be a recurring quarterly pattern.

Financial Impact

Total insider sales of ~$331K, representing 0.0014% of the $24.0B market cap, economically trivial.

insider trading volume (negligible)

Risk Factors

  • No material risk indicated from this insider activity
  • The $24B market cap with 77% bullish consensus already prices in continued execution risk on the PAH (pulmonary arterial hypertension) portfolio and potential generic competition for Remodulin/Tyvaso.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1779484617555

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (11h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026